About Lead Sites
Peter MacCallum Cancer Centre
​305 Grattan Street, Melbourne Victoria
(03) 8559 5000
Peter Mac and the Parkville Precinct run a wide range of cancer clinical trials.
Our clinical trial units test and improve new treatments, interventions, management strategies and treatment experiences from diagnosis to survivorship.
Project Team
Kim Coleman
VAPOR-C Project Manager
Department of Cancer Surgery
Peter MacCallum Cancer Centre
​
Liz Crone
Research Nurse
Anaesthetic Research
Department of Cancer Surgery
Peter MacCallum Cancer Centre
​
Centre for Biostatistics and Clinical Trials (BaCT)
VAPOR-C Data Management
Peter MacCallum Cancer Centre
​
Co-Investigators
Professor David Story
Anaesthesia and Critical Care
University of Melbourne, Australia
Steering Committee Chair
Professor Sandy Heriot
Colorectal Surgery
Peter MacCallum Cancer Centre, Melbourne, Australia
A/Professor Gavin Wright
Thoracic Surgery
St Vincent’s Hospital, Melbourne, Australia
Ms Sabine Braat
Biostatistics
MCATS, University of Melbourne, Australia
Professor Daniel Sessler
Anaesthesia & Outcomes Research
Cleveland Clinic, USA
Professor Donal Buggy
Anaesthesia
University College Dublin, Ireland
Dr An Tran-Duy
Health Economics
MCATS, University of Melbourne, Australia
Dr Jonathan Hiller
Oncoanaesthesia
Peter MacCallum Cancer Centre, Melbourne, Australia
Collaborative Researchers
A/Professor Erica Sloan
Monash Institute of Pharmaceutical Sciences
Monash University, Melbourne, Australia
​
Dr Julia Dubowitz
PhD Candidate,
Monash University, Melbourne, Australia
Coordinating Principal Investigator

Professor Bernhard Riedel
MB.ChB, FCA, FANZCA, FAHA, FASE, MMed, MBA, PhD
​
Bernhard is the Director of the Department of Anesthesia, Perioperative and Pain Medicine at the Peter MacCallum Cancer Centre; Professorial Fellow at the Centre for Integrated Critical Care Medicine and The Sir Peter MacCallum Department of Oncology, University of Melbourne; Clinical Associate Researcher at the Cancer & Neural-Immune Research Laboratory, Monash Institute of Pharmaceutical Sciences.
Previous academic appointments included: Professor and Deputy Chair in Anesthesiology and Intensive Care Medicine at The University of Texas M.D. Anderson Cancer Centre (USA) and Professor in Cardiac Anaesthesiology at Vanderbilt University (USA); and Consultant Cardiac Anaesthesiologist at the Royal Brompton & Harefield NHS Trust (UK).
Bernhard’s academic interests focus on improving surgical outcomes, especially following cancer surgery. Bernhard’s collaborative research program to date has resulted in more than 60 research grants (>$12M), 150 peer-reviewed scientific publications, and 3 edited books (including ‘Acute Care of the Cancer Patient’).
Bernhard’s research interests have improved the understanding of perioperative factors that contribute to complications following major surgery—with strategies for enhanced risk stratification (including measuring functional capacity with cardiopulmonary exercise testing, assessing underlying endothelial dysfunction) and preoperative optimization (including prehabilitation with exercise therapy and haematinic optimization) to reduce complications after surgery.
Specific to the field of onco-anaesthesia, Bernhard’s research collaborative investigates the interaction of perioperative adrenergic-inflammatory response and anaesthetic technique on tumor-progression signaling on the potential long-term postoperative complication—cancer recurrence. Bernhard has been invited to lecture at more than 120 international conferences, including numerous plenary lectures or visiting professorships.
He is the recipient of 11 awards for research, teaching and quality improvement; including a Health Minister award for excellence in clinical quality improvement, and effective mentoring has resulted in more than 30 academic awards to mentees within his team. He currently oversees 4 PhD students and 2 Masters students.
Collaborative International Lead Institutions
Australia
Division of Cancer Surgery
Peter MacCallum Cancer Centre, Melbourne
​
Centre for Biostatistics and Clinical Trials
​
Victorian Comprehensive Cancer Centre (VCCC)
​
Melbourne Clinical and Translational Sciences Platform (MCATS), University of Melbourne
​
St Vincent's Hospital, Melbourne, Australia
​
New Zealand
Auckland District Health Board, Auckland (Dr Doug Campbell and Dr Tim Short)
​
Canada
McMaster University, Hamilton (Professor P.J. Devereaux)
​
European Union
University College Dublin, Ireland (Professor Donal Buggy)
​
​United Kingdom
Imperial College and Royal Brompton & Harefield NHS Trust, London, UK (Dr Nandor Marczin)
USA
Cleveland Clinic (Professor Dan Sessler)
​
M.D. Anderson Cancer Centre (A/Prof Juan Cata)